Assessment of Interactions Between Methamphetamine and Aripiprazole - 1
This trial is unknown status.
|Sponsor||National Institute on Drug Abuse (NIDA)|
|Start date||June 2004|
|End date||March 2005|
|Trial size||17 participants|
|Trial identifier||NCT00089440, NIDA-MDS-0002-1|
The purpose of this study is to assess the interactions between intravenous methamphetamine and aripiprazole.
|United States||No locations recruiting|
|Other Countries||No locations recruiting|
Adverse effect measures
Male or female participants from 18 years up to 45 years old.
Inclusion Criteria: - Must meet DSM-4 criteria for methamphetamine abuse or dependence and are non-treatment seeking. - Ability to verbalize understanding of the consent form, able to provide written informed consent, and verbalize willingness to complete study procedures. Exclusion Criteria: - Please contact the site for more information.
|Official title||Assessment of Interactions Between IV Methamphetamine and Aripiprazole|
|Principal investigator||Thomas Newton, M.D.|
|Description||This is a double-blind, placebo-controlled human laboratory clinical pharmacology study to assess potential interactions between intravenous d-methamphetamine infusion and treatment with oral aripiprazole.|
Call for more information